Hence, e-pharma is at a very nascent stage because it does not even constitute even 1% of the total pharma market. The combined revenue of these online startups is less than 1000 crore per annum. The e-pharma industry is a very small segment which has started flourishing now. Legality Issues: The pharmacy industry in India, i.e., the sale of medicines to end consumers has been estimated to be worth more than 1.2 lakh crore rupees. In this article, we will have a closer look at some of the fundamental issues that are affecting the e-commerce industry. Experts are predicting that some mergers and acquisitions activity might take place to reduce the increasing number of startups that are entering this line of business. The e-pharma start-up space appears to be really heating up. PharmEasy, which is a relatively new entrant, has also been able to obtain $17 million in venture funding. Medlife, which is a similar start-up has raised over $30 million in order to expand its network and last mile connectivity. For example, 1mg has raised more than $50 million in seed funding from American private equity firms. More than 200 start-ups have sprung up in this space, and some of them have gained considerable resources. The e-pharmacy sector in India has been witnessing a lot of startup activity.
0 Comments
Leave a Reply. |